Eversept Partners, Lp
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$1.90B
Q ending 2026-03-31
Prior quarter
$1.98B
Q ending 2025-12-31
Change
-4.4% QoQ · +92.6% YoY
Positions
120
reported holdings
Largest positions
Top 100 of 120 reported positions by value, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| United Therapeutics Corp Del | UTHR | Shares | $156.7M | 264K |
| Invesco Qqq Tr | QQQ | Put | $137.8M | 239K |
| Abivax Sa | ABVX | Shares | $104.0M | 934K |
| Gsk Plc | GSK | Shares | $98.5M | 1.8M |
| Vera Therapeutics Inc | VERA | Shares | $87.4M | 2.2M |
| Natera Inc | NTRA | Shares | $76.9M | 385K |
| State Str Spdr S&P 500 Etf T | SPY | Put | $69.6M | 107K |
| Syndax Pharmaceuticals Inc | SNDX | Shares | $67.4M | 2.9M |
| Celldex Therapeutics Inc New | CLDX | Shares | $56.7M | 1.8M |
| Vaxcyte Inc | PCVX | Shares | $53.7M | 924K |
| Brookdale Sr Living Inc | BKD | Shares | $48.8M | 3.6M |
| Ionis Pharmaceuticals Inc | IONS | Shares | $47.5M | 632K |
| Vertex Pharmaceuticals Inc | VRTX | Call | $40.2M | 90K |
| Hca Healthcare Inc | HCA | Shares | $37.5M | 79K |
| Ishares Tr | TLT | Put | $37.2M | 429K |
| Welltower Inc | WELL | Shares | $35.8M | 181K |
| Healthpeak Properties Inc | DOC | Shares | $32.5M | 2.0M |
| Insulet Corp | PODD | Shares | $30.1M | 144K |
| Biocryst Pharmaceuticals Inc | BCRX | Shares | $28.9M | 3.0M |
| Geron Corp | GERN | Shares | $28.1M | 18.8M |
| Omega Healthcare Invs Inc | OHI | Shares | $25.7M | 586K |
| Liquidia Corporation | LQDA | Shares | $25.6M | 677K |
| Community Health Sys Inc New | CYH | Shares | $25.5M | 8.7M |
| Avantor Inc | AVTR | Shares | $23.3M | 3.0M |
| Qiagen Nv | Shares | $21.8M | 545K | |
| Qiagen Nv | Call | $19.1M | 476K | |
| Encompass Health Corp | EHC | Shares | $18.8M | 194K |
| Eli Lilly & Co | LLY | Shares | $17.5M | 19K |
| Travere Therapeutics Inc | TVTX | Shares | $16.1M | 543K |
| Insmed Inc | INSM | Call | $15.4M | 94K |
| Cytomx Therapeutics Inc. | CTMX | Shares | $15.0M | 3.2M |
| Ishares Tr | HYG | Put | $14.3M | 180K |
| Repligen Corp | RGEN | Shares | $14.2M | 121K |
| Beta Bionics Inc | BBNX | Shares | $14.2M | 1.4M |
| Viridian Therapeutics Inc | VRDN | Shares | $14.0M | 713K |
| Arcutis Biotherapeutics Inc | ARQT | Shares | $13.6M | 577K |
| Ardelyx Inc | ARDX | Shares | $13.4M | 2.2M |
| Ltc Pptys Inc | LTC | Shares | $11.9M | 321K |
| Biomarin Pharmaceutical Inc | BMRN | Shares | $11.7M | 208K |
| Chemed Corp New | CHE | Shares | $11.7M | 31K |
| Pharvaris N V | Shares | $11.5M | 407K | |
| Unitedhealth Group Inc | UNH | Call | $10.8M | 40K |
| Ishares Tr | IWM | Put | $9.9M | 40K |
| Pennant Group Inc | PNTG | Shares | $9.5M | 312K |
| Select Sector Spdr Tr | XLK | Put | $9.3M | 70K |
| Newamsterdam Pharma Company | Shares | $9.1M | 286K | |
| Palisade Bio Inc | PALI | Shares | $8.7M | 5.0M |
| Moderna Inc | MRNA | Shares | $8.1M | 160K |
| Viking Therapeutics Inc | VKTX | Shares | $7.8M | 239K |
| Icon Plc | Shares | $7.6M | 69K | |
| Xenon Pharmaceuticals Inc | XENE | Shares | $7.5M | 130K |
| Revvity Inc | RVTY | Shares | $7.4M | 85K |
| Agios Pharmaceuticals Inc | AGIO | Shares | $6.8M | 200K |
| Structure Therapeutics Inc | GPCR | Shares | $6.7M | 138K |
| Bio-Techne Corp | TECH | Shares | $6.6M | 126K |
| Glaukos Corp | GKOS | Shares | $6.5M | 60K |
| Tenet Healthcare Corp | THC | Shares | $5.6M | 30K |
| Madrigal Pharmaceuticals Inc | MDGL | Shares | $5.2M | 10K |
| Intuitive Surgical Inc | ISRG | Shares | $5.1M | 11K |
| Praxis Precision Medicines I | PRAX | Put | $4.8M | 15K |
| Esperion Therapeutics Inc Ne | Shares | $4.8M | 1.7M | |
| Molina Healthcare Inc | MOH | Shares | $4.4M | 33K |
| Healthequity Inc | HQY | Shares | $4.3M | 52K |
| Bruker Corp | BRKR | Shares | $4.2M | 117K |
| Day One Biopharmaceuticals I | DAWNGBX | Shares | $3.9M | 184K |
| Spdr Series Trust | XBI | Put | $3.8M | 30K |
| Compass Pathways Plc | CMPS | Shares | $3.7M | 678K |
| Centene Corp Del | CNC | Shares | $3.7M | 112K |
| Grace Therapeutics Inc | GRCE | Shares | $3.5M | 757K |
| Engene Holdings Inc | Shares | $3.5M | 511K | |
| Universal Hlth Svcs Inc | UHS | Put | $3.3M | 18K |
| Enhabit Inc | EHABUSD | Shares | $3.2M | 227K |
| Select Sector Spdr Tr | XLE | Call | $3.1M | 50K |
| Definium Therapeutics Inc | DFTX | Shares | $3.0M | 161K |
| Equillium Inc | EQ | Shares | $3.0M | 1.5M |
| Ensign Group Inc | ENSG | Shares | $3.0M | 15K |
| Invivyd Inc | IVVD | Shares | $3.0M | 2.3M |
| Pmv Pharmaceuticals Inc | PMVP | Shares | $2.9M | 2.3M |
| Alector Inc | ALEC | Shares | $2.9M | 1.4M |
| Alto Neuroscience Inc | ANRO | Shares | $2.8M | 125K |
| Relay Therapeutics Inc | RLAY | Shares | $2.7M | 271K |
| Replimune Group Inc | REPL | Shares | $2.6M | 335K |
| Lb Pharmaceuticals Inc | LBRX | Shares | $2.5M | 100K |
| Lipocine Inc New | LPCN | Shares | $2.4M | 295K |
| Vir Biotechnology Inc | VIR | Shares | $2.2M | 250K |
| Anteris Technologies Global | AVR | Shares | $2.2M | 401K |
| Amarin Corp Plc | AMRN | Shares | $2.1M | 148K |
| Savara Inc | SVRA | Shares | $2.1M | 384K |
| Relmada Therapeutics Inc | RLMD | Shares | $1.9M | 278K |
| Contineum Therapeutics Inc | CTNM | Shares | $1.9M | 146K |
| Sutro Biopharma Inc | STRO | Shares | $1.8M | 73K |
| Inovio Pharmaceuticals Inc | INO | Shares | $1.8M | 1.0M |
| Surrozen Inc | SRZN | Shares | $1.7M | 59K |
| Inflarx Nv | Shares | $1.6M | 1.8M | |
| Karyopharm Therapeutics Inc | KPTI | Shares | $1.5M | 276K |
| Anaptysbio Inc | ANAB | Shares | $1.5M | 27K |
| Novocure Ltd | Shares | $1.5M | 135K | |
| Bioventus Inc | BVS | Shares | $1.5M | 159K |
| Agilon Health Inc | AGL | Shares | $1.4M | 177K |
| Ultragenyx Pharmaceutical In | RARE | Shares | $1.3M | 63K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.